Sukem Pharmaceuticals Private Limited
About Sukem Pharmaceuticals Private Limited
Data last updated:
Sukem Pharmaceuticals Private Limited is a private limited company based in New Delhi, Delhi, India. It operates in the specialised retail segment of the home appliances and consumer durables sector. It was incorporated on 01 October 2015 and has been in existence for over 11 years.
The company is registered with the Registrar of Companies (ROC), Delhi, under CIN U52311DL2015PTC285892. Its GSTIN is 09AAWCS6022K1ZP (Uttar Pradesh).
The company has an authorised share capital of ₹1 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors Dinesh Kumar and Yogendra Singh.
Its last annual general meeting (AGM) was held on 01 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at 1833 – A – 19 Gali No.10 Sf Govindpuri, New Delhi, Delhi, India – 110019.
As per the financials filed for FY 2025, the company reported a revenue of ₹12.9 Lakh, a growth of 7% compared to the previous year. For the same year it recorded a net profit of ₹16,753 (net margin 1.3%) and EBITDA of ₹19,353 (EBITDA margin 1.5%). Revenue has grown at a compounded annual rate (CAGR) of 33% over three years and 29% over five years.
The current compliance status is marked as compliant by the Registrar of Companies.
Company details
Contact details
Sukem Pharmaceuticals Private Limited's registered office is in New Delhi, Delhi. Its e-mail address is in the company report.
- Email
- Registered Address1833 – A – 19 Gali No.10 Sf Govindpuri, New Delhi, Delhi, India – 110019
- IndustryHome Appliances, Specialized Stores, Retailers
To see the full contact details of Sukem Pharmaceuticals Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Sukem Pharmaceuticals is trade. In detail, this covers wholesale trading.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| G | Trade | G1 | Wholesale Trading |
To see the full business activity and turnover split of Sukem Pharmaceuticals Private Limited, buy the company report.
Financials of Sukem Pharmaceuticals Private Limited
FY 2025 filings availableSukem Pharmaceuticals Private Limited reported revenue of ₹12.9 Lakh (up 7% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR)
Revenue has grown at a compounded annual rate (CAGR) of 29% over five years, including 7% growth in the latest year. EBITDA rose 137% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹19,353 | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹16,753 | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 1.5% | ||||
| Net Profit Margin | 1.3% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Sukem Pharmaceuticals Private Limited, buy the company report.
Board of directors of Sukem Pharmaceuticals Private Limited
Sukem Pharmaceuticals has 2 current directors and 2 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Dinesh Kumar | Director | 01 Oct 2015 | 11 Years 1 Months | Current |
| Yogendra Singh | Director | 16 May 2020 | 6 Years 5 Months | Current |
Peer comparison
Sukem Pharmaceuticals Private Limited is compared with the 4 companies closest to it by revenue in the Pharma industry (Pharmaceuticals), with the same principal business activity (wholesale trading), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Sporelin Pharmaceuticals Private Limited | ₹12.95 Lakh (FY 2019) | -38.0% | Aurangabad, Maharashtra, India | |||
| MGD Pharmaceuticals Private Limited | ₹12.91 Lakh (FY 2024) | 690.0% | Thane, Maharashtra, India | |||
| Pinklap Pharmaceuticals Private Limited | ₹12.9 Lakh (FY 2020) | Badlapur, Thane, Maharashtra, India | ||||
| Sukem Pharmaceuticals Private Limitedthis company | ₹12.9 Lakh (FY 2025) | ₹16,753 | 1.3% | 7.0% | New Delhi, Delhi, India | |
| Stile Pharmaceuticals Private Limited | ₹12.88 Lakh (FY 2024) | -9.0% | Thane, Maharashtra, India |
To see the full peer comparison of Sukem Pharmaceuticals Private Limited, buy the company report.
Auditor
Sukem Pharmaceuticals Private Limited is audited by SINGHAL RAHUL & CO. for the financial year 2017.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| SINGHAL RAHUL & CO. | FY 2017 | 020168C |
Shareholding
The shareholding of Sukem Pharmaceuticals Private Limited is on record for 2 financial years, the latest being FY 2017, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2017 | FY 2016 |
|---|---|---|
| Promoters | ||
| Domestic institutional investors (DII) | ||
| Foreign institutional investors (FII) | ||
| Public | ||
| Others |
To see the full shareholding pattern of Sukem Pharmaceuticals Private Limited, buy the company report.
Legal cases
No court or tribunal cases involving Sukem Pharmaceuticals Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Sukem Pharmaceuticals Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Sukem Pharmaceuticals has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 09AAWCS6022K1ZP | Uttar Pradesh | Active | 01 Jul 2017 |
To see the full GST registrations and return filing status of Sukem Pharmaceuticals Private Limited, buy the company report.
Recent activity
Sukem Pharmaceuticals Private Limited has 4 board changes on record since 2015: 2 appointments and 2 cessations. The latest: Yogendra Singh ceased to be Additional Director on 28 Oct 2020.
Frequently asked questions
Sukem Pharmaceuticals is an active private limited company based in New Delhi, Delhi, India. The company works in specialized stores, within the home appliances industry. It was incorporated on 01 October 2015 (11+ years old) and is registered under CIN U52311DL2015PTC285892.
Sukem Pharmaceuticals has 2 current directors:
- Dinesh Kumar - Director
- Yogendra Singh - Director
The latest financial statements of Sukem Pharmaceuticals on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 01 September 2025. Year-wise statements from FY 2016 are in the company report.
The GSTIN of Sukem Pharmaceuticals is 09AAWCS6022K1ZP, registered in Uttar Pradesh.
The CIN (Corporate Identification Number) of Sukem Pharmaceuticals is U52311DL2015PTC285892. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Sukem Pharmaceuticals was incorporated on 01 October 2015, making it 11+ years old. It is registered with the Registrar of Companies, Delhi.
The peers of Sukem Pharmaceuticals by revenue are Sporelin Pharmaceuticals Private Limited, MGD Pharmaceuticals Private Limited, Pinklap Pharmaceuticals Private Limited, Stile Pharmaceuticals Private Limited, all in the Pharma industry (Pharmaceuticals), with the same principal business activity (wholesale trading).
Yogendra Singh ceased to be Additional Director on 28 Oct 2020. Yogendra Singh was appointed as Director on 16 May 2020. Bhanu Pratap Singh ceased to be Director on 07 May 2020. Sukem Pharmaceuticals has 4 board changes on record in total.
The registered office of Sukem Pharmaceuticals is at 1833 – A – 19 Gali No.10 Sf Govindpuri, New Delhi, Delhi, India – 110019.
Sukem Pharmaceuticals operates in the home appliances industry, in the specialized stores segment.
The compliance status of Sukem Pharmaceuticals is compliant as of 15 August 2026. The company is actively filing with the Registrar of Companies.
Sample company reports
The same report you get when you buy one: financials, directors, ownership, deals, charges, legal cases, brands and filings, with the Excel workbook alongside.
